News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
99,140 Results
Type
Article (7352)
Company Profile (34)
Press Release (91751)
Multimedia
Podcasts (17)
Webinars (3)
Section
Business (30614)
Career Advice (298)
Deals (3998)
Drug Delivery (38)
Drug Development (12008)
Employer Resources (21)
FDA (2144)
Job Trends (2684)
News (45449)
Policy (3977)
Tag
2025 Best Places to Work (3)
2026 Best Places to Work (3)
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Genetown Standard (1)
40 Under 40 (1)
Academia (788)
Accelerated approval (9)
ADA (7)
Adcomms (5)
Allergies (25)
Alliances (8706)
ALS (46)
Alzheimer's disease (243)
Antibody-drug conjugate (ADC) (124)
Approvals (2235)
Artificial intelligence (239)
ASCO (79)
Autoimmune disease (59)
Automation (22)
Bankruptcy (35)
Belgium (3)
Best Places to Work (2295)
BIO (6)
Biologics (12)
BIOSECURE Act (13)
Biosimilars (32)
BioSpace Insights (30)
Biotechnology (26)
Bispecific (18)
Bladder cancer (43)
Brain cancer (21)
Breast cancer (256)
Cancer (1703)
Cardiovascular disease (125)
Career advice (279)
Career pathing (16)
CAR-T (97)
CDC (10)
CDMO (44)
Celiac Disease (2)
Cell therapy (273)
Cervical cancer (10)
Clinical research (10545)
Collaboration (562)
Commercialization (8)
Company closure (1)
Compensation (170)
Complete response letters (8)
COVID-19 (527)
CRISPR (72)
C-suite (253)
Cystic fibrosis (20)
Data (1955)
Decentralized trials (1)
Denatured (1)
Depression (15)
Dermatology (21)
Diabetes (104)
Diagnostics (2003)
Digital health (14)
Diversity (1)
Diversity, equity & inclusion (10)
Drug discovery (107)
Drug pricing (23)
Drug shortages (3)
Duchenne muscular dystrophy (57)
Earnings (9549)
Editorial (7)
Employer branding (3)
Employer resources (24)
ESMO (93)
Events (13924)
Executive appointments (219)
Eye disease (2)
FDA (2894)
Fragile X (2)
Friedreich's ataxia (7)
Frontotemporal dementia (4)
Funding (379)
Gene editing (161)
Generative AI (15)
Gene therapy (237)
GLP-1 (172)
Government (847)
Grass and pollen (1)
Guidances (67)
Healthcare (3011)
Hematology (46)
HIV (16)
Huntington's disease (20)
IgA nephropathy (11)
Immunology and inflammation (32)
Immuno-oncology (25)
Indications (43)
Infectious disease (592)
Inflammatory bowel disease (27)
Inflation Reduction Act (4)
Influenza (17)
Intellectual property (41)
Interviews (47)
IPO (1907)
IRA (5)
Job creations (438)
Job search strategy (225)
JPM (12)
Kidney disease (45)
Labor market (29)
Layoffs (62)
Leadership (17)
Legal (616)
Licensing (12)
Liver cancer (24)
Longevity (14)
Lung cancer (247)
Lymphoma (111)
Machine learning (22)
Management (8)
Manufacturing (205)
Marketing (2)
MASH (22)
Medical affairs (1)
Medical device (1219)
Medtech (1245)
Melanoma (49)
Mergers & acquisitions (2269)
Metabolic disorders (219)
mRNA (69)
Multiple sclerosis (23)
NASH (2)
Netherlands (7)
Neurodegenerative disease (88)
Neuropsychiatric disorders (12)
Neuroscience (525)
Neurotech (1)
NextGen: Class of 2026 (1009)
Non-profit (878)
Now hiring (22)
Obesity (89)
Opinion (84)
Ovarian cancer (35)
Pain (44)
Pancreatic cancer (115)
Parkinson's disease (60)
Partnered (8)
Patents (88)
Patient advocacy (3)
Patient recruitment (108)
Patient selection (15)
Peanut (7)
People (9067)
Peptides (8)
Pharmaceutical (3)
Pharmacy benefit managers (5)
Phase 1 (3763)
Phase 2 (4745)
Phase 3 (3355)
Pipeline (2150)
Policy (61)
Postmarket research (353)
Preclinical (1331)
Press Release (24)
Prostate cancer (65)
Psychedelics (8)
Radioligand (1)
Radiopharmaceuticals (26)
Rare diseases (320)
Real estate (781)
Recruiting (9)
Regenerative medicine (6)
Regulatory (3490)
Reports (11)
Research institute (808)
Resumes & cover letters (26)
Rett syndrome (11)
RNA editing (5)
RSV (6)
Schizophrenia (24)
Series A (62)
Series B (33)
Sickle cell disease (42)
Special edition (5)
Spinal muscular atrophy (29)
Sponsored (11)
Startups (653)
State (1)
Stem cells (3)
Stomach cancer (5)
Substance use disorders (2)
Supply chain (19)
Switzerland (4)
Tariffs (8)
The Weekly (15)
Vaccines (202)
Venture capital (31)
Weight loss (58)
Wet AMD (1)
Women's health (15)
Worklife (2)
Date
Today (17)
Last 7 days (103)
Last 30 days (568)
Last 365 days (4441)
2026 (4077)
2025 (4277)
2024 (5361)
2023 (6125)
2022 (8177)
2021 (8626)
2020 (7944)
2019 (7095)
2018 (5274)
2017 (4975)
2016 (4724)
2015 (5147)
2014 (3538)
2013 (2882)
2012 (3026)
2011 (3188)
2010 (2605)
Location
Africa (150)
Alabama (16)
Alaska (2)
Arizona (99)
Arkansas (1)
Asia (5865)
Australia (844)
California (2686)
Canada (555)
China (295)
Colorado (96)
Connecticut (120)
Delaware (56)
Europe (13523)
Florida (319)
Georgia (45)
Hawaii (2)
Idaho (3)
Illinois (164)
India (22)
Indiana (82)
Iowa (16)
Japan (162)
Kansas (18)
Kentucky (9)
Louisiana (11)
Maine (11)
Maryland (316)
Massachusetts (1717)
Michigan (27)
Minnesota (80)
Mississippi (1)
Missouri (25)
Montana (6)
Nebraska (8)
Nevada (21)
New Hampshire (7)
New Jersey (631)
New Mexico (12)
New York (590)
North Carolina (418)
North Dakota (10)
Northern California (1516)
Ohio (70)
Oklahoma (5)
Oregon (10)
Pennsylvania (364)
Puerto Rico (2)
Rhode Island (19)
South America (149)
South Carolina (9)
Southern California (931)
Tennessee (30)
Texas (483)
United States (8559)
Utah (74)
Virginia (42)
Washington D.C. (7)
Washington State (143)
West Virginia (1)
Wisconsin (35)
Wyoming (3)
99,140 Results for "seven bridges genomics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tsingke Bridges AI-Driven Molecular Design and Real-World Experimentation with Automated Manufacturing
November 6, 2026
·
2 min read
Opinion
Biotechs going to market alone must learn to go global
Drug developers increasingly have the option of seeking regulatory approval and commercializing a medicine themselves, rather than accepting an early exit offer. Doing so requires a worldwide strategy.
October 28, 2026
·
3 min read
·
Paul Bridges
Press Releases
TELO Genomics Expands Multi-Center Clinical Studies to Advance Comparative Validation of TELO-MRD Against Next-Generation Sequencing
In matched multi-center cohorts, Telo Genomics is expanding comparative evaluation of blood-based TELO-MRD against Adaptive Biotechnologies’ clonoSEQ next-generation sequencing MRD testing.
October 29, 2026
·
6 min read
Press Releases
Telo Genomics Announces Term Sheet Providing an Option for Exclusive Worldwide License to AI Technology for Automated Detection of Rare Malignant Cells
Agreement with the University of Manitoba and Technion Research and Development Foundation Ltd. provides an option for a license that could expand Telo Genomics’ liquid-biopsy platform for cancer screening, diagnosis, treatment selection and disease monitoring.
November 18, 2026
·
6 min read
Press Releases
Glioblastoma Foundation’s Genomic Testing & Research Laboratory Now Accepting Patient Samples for Genomic Testing
November 1, 2026
·
4 min read
Press Releases
Onconetix Provides Additional Strategic Bridge Financing to Realbotix LLC in Continued Support of Pending Acquisition
October 23, 2026
·
7 min read
Press Releases
Telo Genomics Provides Positive Interim Data from Ongoing Clinical Trial Advancing Genomic Instability-Based Relapse Risk Assessment
Clinical Study on Track to Meet Primary Endpoints with Interim Data Demonstrating Blood-Based Assay Capable of Predicting Relapse Risk Through Analysis of Genomic Instability and Telomere Architecture
July 16, 2026
·
8 min read
Press Releases
Innovent Announces Seven Innovative Products Including Mazdutide and PECONDLE® Successfully Included in the 2026 National Reimbursement Drug List
November 15, 2026
·
11 min read
Press Releases
Bridge Neurotech and Butterfly Network Announce Partnership to Develop Fully Non-Invasive Brain-Computer Interface
October 7, 2026
·
3 min read
Press Releases
Lupus Research Alliance Announces 2026 Translational Bridge Awards to Accelerate Promising Lupus Therapies
September 23, 2026
·
4 min read
1 of 9,914
Next